$CYTR Recent Headlines Micron Tech shares fall
Post# of 44860
Posted On: 01/17/2015 11:51:08 AM
$CYTR Recent Headlines
Micron Tech shares fall after revenue miss 4:57 p.m. Jan. 6, 2015 - Wallace Witkowski
Six stocks to watch 2:29 p.m. Jan. 22, 2014 - The Trading Deck
CytRx's stock spike proves to be no fluke with another 20% share gain 11:39 a.m. Dec. 12, 2013 - Russ Britt
MasterCard, Visa among top S&P gainers; Avon in red 4:27 p.m. Dec. 11, 2013 - Sue Chang
Cancer drug test results send CytRx shares soaring by 75% 10:48 a.m. Dec. 11, 2013 - Russ Britt
CytRx jumps on results of aldoxorubicin trial 9:47 a.m. Dec. 11, 2013 - MarketWatch.com
Yum shares drop on outlook, soft China sales 5:10 p.m. Oct. 8, 2013 - Wallace Witkowski
Six companies unveil share, unit offerings 7:45 a.m. Dec. 7, 2012 - MarketWatch.com
Insider filings one way to track tricky micro-cap biotechs 11:14 a.m. Oct. 24, 2012 - blogs.marketwatch.com
CytRx prices offering at 20% discount 10:07 a.m. Oct. 18, 2012 - MarketWatch.com
CytRx down 20.6% in premarket 7:59 a.m. Oct. 18, 2012 - Steve Gelsi
CytRx rallies 27% on drug study update 11:49 a.m. July 25, 2012 - Val Brickates Kennedy
CytRx falls 12% in morning trading 10:02 a.m. June 4, 2012 - Val Brickates Kennedy
Thursday’s biggest gaining and declining stocks 3:40 p.m. April 28, 2011 - Kate Gibson
Dyax, Santarus, CytRx soar; Hemispherx craters 11:38 a.m. Dec. 2, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 5:00 p.m. June 30, 2009 - MarketWatch
Drug stocks retract; Vical, Geron, Novavax soar 1:29 p.m. June 30, 2009 - Val Brickates Kennedy
CytRx files FDA report on halted clinical trial 8:16 a.m. June 30, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 4:39 p.m. Jan. 22, 2008 - MarketWatch
Drug stocks tumble on U.S. economy jitters; CytRx slumps 1:33 p.m. Jan. 22, 2008 - Val Brickates Kennedy
CytRx up on interim trial results for KS in HIV patients 9:50 a.m. Jan. 8, 2015 - Seeking Alpha
CytRx Jumps on Positive Results from Brain Cancer Study - Analyst Blog 2:16 p.m. Jan. 7, 2015 - Zacks.com
4 Biotechnology Stocks to Sell Now 1:30 a.m. Jan. 7, 2015 - InvestorPlace.com
CytRx up on brain cancer trial results 9:03 a.m. Jan. 6, 2015 - Seeking Alpha
CytRx Reports Positive Results for Brain Cancer Treatment 8:02 a.m. Jan. 6, 2015 - The Wall Street Journal Interactive Edition
Nominees for Absolute Worst Bio-Technology CEOs of 2014 Are ... 11:49 a.m. Dec. 15, 2014 - TheStreet.com
CytRx Falls on Written FDA Notice for Aldoxorubicin Study - Analyst Blog 5:20 p.m. Dec. 4, 2014 - Zacks.com
Five Biotech Firms Whose Stock-Promoting Efforts Didn't Pay Off 11:00 a.m. Dec. 2, 2014 - TheStreet.com
CytRx Falls on Partial Study Hold on Oncology Candidate - Analyst Blog 5:21 p.m. Nov. 19, 2014 - Zacks.com
Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst Blog 11:23 a.m. Nov. 19, 2014 - Zacks.com
CytRx off premarket in response to FDA hold on aldoxorubicin trials 8:53 a.m. Nov. 18, 2014 - Seeking Alpha
More Fallout From Stock Promotion Scandal 2:35 p.m. Nov. 14, 2014 - Seeking Alpha
10-Q: CYTRX CORP 6:05 a.m. Nov. 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
5 Red-Hot Biotech Stocks to Buy 4:33 a.m. Oct. 27, 2014 - InvestorPlace.com
Three Lessons From The Galena Scandal 10:02 a.m. Aug. 21, 2014 - Seeking Alpha
RXi Pharmaceuticals: Early-Stage Biotech With A Promising Future 4:22 p.m. Aug. 4, 2014 - Seeking Alpha
Biotech Accused in Stock-Pump Scheme 10:11 a.m. July 8, 2014 - Barrons.com
Five Analyst Stock Picks With 100% or More Implied Upside 7:31 a.m. June 7, 2014 - 247WallSt.com
Celldex: The Race Leader In Glioblastoma Multiforme 2:17 p.m. May 29, 2014 - Seeking Alpha
Aldoxorubicin increases PFS 6:53 a.m. May 28, 2014 - Seeking Alpha
Driving the Market: Special Research on Twitter, Frontline, CytRx, Tonix and American Electric 8:40 a.m. Jan. 7, 2015 - PR Newswire - PRF
CytRx Announces Positive Interim Phase 2 Aldoxorubicin Results in Glioblastoma Multiforme (Brain Cancer) 6:00 a.m. Jan. 6, 2015 - PR Newswire - PRF
CytRx Receives Written FDA Communication Regarding Partial Clinical Hold for Aldoxorubicin Clinical Trials 6:00 a.m. Dec. 3, 2014 - PR Newswire - PRF
CytRx to Present at the Oppenheimer 25th Annual Healthcare Conference 6:00 a.m. Dec. 2, 2014 - PR Newswire - PRF
CytRx Announces Partial Clinical Hold Affecting Aldoxorubicin Clinical Trials 6:00 a.m. Nov. 18, 2014 - PR Newswire - PRF
CytRx Reports 2014 Third Quarter Financial Results 6:00 a.m. Nov. 4, 2014 - PR Newswire - PRF
CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 5:00 a.m. Oct. 30, 2014 - PR Newswire - PRF
CytRx Announces Publication of Preclinical Glioblastoma Data in Neoplasia 5:00 a.m. Oct. 29, 2014 - PR Newswire - PRF
Big Board Biotech Stocks in Play This Week 1:17 p.m. Oct. 28, 2014 - ACCESSWIRE
Big Board Biotech Stocks in Play This Week 10:22 a.m. Oct. 28, 2014 - ACCESSWIRE
Big Board Biotech Stocks in Play This Week 10:22 a.m. Oct. 28, 2014 - ACCESSWIRE
Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 8:00 a.m. Oct. 24, 2014 - PR Newswire - PRF
CytRx Announces Publication of Phase 1b/2 Aldoxorubicin Clinical Data in Soft Tissue Sarcoma in Cancer, the Peer-Reviewed Journal of the American Cancer Society 5:00 a.m. Oct. 20, 2014 - PR Newswire - PRF
CytRx to Present Data from Global Phase 2b Clinical Trial of Aldoxorubicin in First-Line Soft Tissue Sarcoma at 2014 CTOS Annual Meeting 5:00 a.m. Oct. 17, 2014 - PR Newswire - PRF
CytRx Appoints Steven A. Kriegsman as Chairman of the Board 5:00 a.m. Oct. 16, 2014 - PR Newswire - PRF
CytRx Launches Discovery Laboratory to Develop Albumin-Binding Anti-Cancer Drug Platform 5:00 a.m. Oct. 13, 2014 - PR Newswire - PRF
CytRx Initiates Phase 1b Clinical Trial with Combination of Aldoxorubicin and Gemcitabine in Patients with Metastatic Solid Tumors 5:00 a.m. Oct. 9, 2014 - PR Newswire - PRF
CytRx Announces Unexpected Passing of Chairman Max Link, PhD 3:05 p.m. Oct. 7, 2014 - PR Newswire - PRF
CytRx Initiates Global Phase 2b Clinical Trial of Aldoxorubicin for the Treatment of Relapsed/Refractory Small Cell Lung Cancer 5:00 a.m. Sept. 30, 2014 - PR Newswire - PRF
CytRx Receives Multiple FDA Orphan Drug Designations for Aldoxorubicin for the Treatment of Glioblastoma, Small Cell Lung Cancer and Ovarian Cancer 5:00 a.m. Sept. 29, 2014 - PR Newswire - PRF
Micron Tech shares fall after revenue miss 4:57 p.m. Jan. 6, 2015 - Wallace Witkowski
Six stocks to watch 2:29 p.m. Jan. 22, 2014 - The Trading Deck
CytRx's stock spike proves to be no fluke with another 20% share gain 11:39 a.m. Dec. 12, 2013 - Russ Britt
MasterCard, Visa among top S&P gainers; Avon in red 4:27 p.m. Dec. 11, 2013 - Sue Chang
Cancer drug test results send CytRx shares soaring by 75% 10:48 a.m. Dec. 11, 2013 - Russ Britt
CytRx jumps on results of aldoxorubicin trial 9:47 a.m. Dec. 11, 2013 - MarketWatch.com
Yum shares drop on outlook, soft China sales 5:10 p.m. Oct. 8, 2013 - Wallace Witkowski
Six companies unveil share, unit offerings 7:45 a.m. Dec. 7, 2012 - MarketWatch.com
Insider filings one way to track tricky micro-cap biotechs 11:14 a.m. Oct. 24, 2012 - blogs.marketwatch.com
CytRx prices offering at 20% discount 10:07 a.m. Oct. 18, 2012 - MarketWatch.com
CytRx down 20.6% in premarket 7:59 a.m. Oct. 18, 2012 - Steve Gelsi
CytRx rallies 27% on drug study update 11:49 a.m. July 25, 2012 - Val Brickates Kennedy
CytRx falls 12% in morning trading 10:02 a.m. June 4, 2012 - Val Brickates Kennedy
Thursday’s biggest gaining and declining stocks 3:40 p.m. April 28, 2011 - Kate Gibson
Dyax, Santarus, CytRx soar; Hemispherx craters 11:38 a.m. Dec. 2, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 5:00 p.m. June 30, 2009 - MarketWatch
Drug stocks retract; Vical, Geron, Novavax soar 1:29 p.m. June 30, 2009 - Val Brickates Kennedy
CytRx files FDA report on halted clinical trial 8:16 a.m. June 30, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 4:39 p.m. Jan. 22, 2008 - MarketWatch
Drug stocks tumble on U.S. economy jitters; CytRx slumps 1:33 p.m. Jan. 22, 2008 - Val Brickates Kennedy
CytRx up on interim trial results for KS in HIV patients 9:50 a.m. Jan. 8, 2015 - Seeking Alpha
CytRx Jumps on Positive Results from Brain Cancer Study - Analyst Blog 2:16 p.m. Jan. 7, 2015 - Zacks.com
4 Biotechnology Stocks to Sell Now 1:30 a.m. Jan. 7, 2015 - InvestorPlace.com
CytRx up on brain cancer trial results 9:03 a.m. Jan. 6, 2015 - Seeking Alpha
CytRx Reports Positive Results for Brain Cancer Treatment 8:02 a.m. Jan. 6, 2015 - The Wall Street Journal Interactive Edition
Nominees for Absolute Worst Bio-Technology CEOs of 2014 Are ... 11:49 a.m. Dec. 15, 2014 - TheStreet.com
CytRx Falls on Written FDA Notice for Aldoxorubicin Study - Analyst Blog 5:20 p.m. Dec. 4, 2014 - Zacks.com
Five Biotech Firms Whose Stock-Promoting Efforts Didn't Pay Off 11:00 a.m. Dec. 2, 2014 - TheStreet.com
CytRx Falls on Partial Study Hold on Oncology Candidate - Analyst Blog 5:21 p.m. Nov. 19, 2014 - Zacks.com
Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst Blog 11:23 a.m. Nov. 19, 2014 - Zacks.com
CytRx off premarket in response to FDA hold on aldoxorubicin trials 8:53 a.m. Nov. 18, 2014 - Seeking Alpha
More Fallout From Stock Promotion Scandal 2:35 p.m. Nov. 14, 2014 - Seeking Alpha
10-Q: CYTRX CORP 6:05 a.m. Nov. 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
5 Red-Hot Biotech Stocks to Buy 4:33 a.m. Oct. 27, 2014 - InvestorPlace.com
Three Lessons From The Galena Scandal 10:02 a.m. Aug. 21, 2014 - Seeking Alpha
RXi Pharmaceuticals: Early-Stage Biotech With A Promising Future 4:22 p.m. Aug. 4, 2014 - Seeking Alpha
Biotech Accused in Stock-Pump Scheme 10:11 a.m. July 8, 2014 - Barrons.com
Five Analyst Stock Picks With 100% or More Implied Upside 7:31 a.m. June 7, 2014 - 247WallSt.com
Celldex: The Race Leader In Glioblastoma Multiforme 2:17 p.m. May 29, 2014 - Seeking Alpha
Aldoxorubicin increases PFS 6:53 a.m. May 28, 2014 - Seeking Alpha
Driving the Market: Special Research on Twitter, Frontline, CytRx, Tonix and American Electric 8:40 a.m. Jan. 7, 2015 - PR Newswire - PRF
CytRx Announces Positive Interim Phase 2 Aldoxorubicin Results in Glioblastoma Multiforme (Brain Cancer) 6:00 a.m. Jan. 6, 2015 - PR Newswire - PRF
CytRx Receives Written FDA Communication Regarding Partial Clinical Hold for Aldoxorubicin Clinical Trials 6:00 a.m. Dec. 3, 2014 - PR Newswire - PRF
CytRx to Present at the Oppenheimer 25th Annual Healthcare Conference 6:00 a.m. Dec. 2, 2014 - PR Newswire - PRF
CytRx Announces Partial Clinical Hold Affecting Aldoxorubicin Clinical Trials 6:00 a.m. Nov. 18, 2014 - PR Newswire - PRF
CytRx Reports 2014 Third Quarter Financial Results 6:00 a.m. Nov. 4, 2014 - PR Newswire - PRF
CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 5:00 a.m. Oct. 30, 2014 - PR Newswire - PRF
CytRx Announces Publication of Preclinical Glioblastoma Data in Neoplasia 5:00 a.m. Oct. 29, 2014 - PR Newswire - PRF
Big Board Biotech Stocks in Play This Week 1:17 p.m. Oct. 28, 2014 - ACCESSWIRE
Big Board Biotech Stocks in Play This Week 10:22 a.m. Oct. 28, 2014 - ACCESSWIRE
Big Board Biotech Stocks in Play This Week 10:22 a.m. Oct. 28, 2014 - ACCESSWIRE
Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 8:00 a.m. Oct. 24, 2014 - PR Newswire - PRF
CytRx Announces Publication of Phase 1b/2 Aldoxorubicin Clinical Data in Soft Tissue Sarcoma in Cancer, the Peer-Reviewed Journal of the American Cancer Society 5:00 a.m. Oct. 20, 2014 - PR Newswire - PRF
CytRx to Present Data from Global Phase 2b Clinical Trial of Aldoxorubicin in First-Line Soft Tissue Sarcoma at 2014 CTOS Annual Meeting 5:00 a.m. Oct. 17, 2014 - PR Newswire - PRF
CytRx Appoints Steven A. Kriegsman as Chairman of the Board 5:00 a.m. Oct. 16, 2014 - PR Newswire - PRF
CytRx Launches Discovery Laboratory to Develop Albumin-Binding Anti-Cancer Drug Platform 5:00 a.m. Oct. 13, 2014 - PR Newswire - PRF
CytRx Initiates Phase 1b Clinical Trial with Combination of Aldoxorubicin and Gemcitabine in Patients with Metastatic Solid Tumors 5:00 a.m. Oct. 9, 2014 - PR Newswire - PRF
CytRx Announces Unexpected Passing of Chairman Max Link, PhD 3:05 p.m. Oct. 7, 2014 - PR Newswire - PRF
CytRx Initiates Global Phase 2b Clinical Trial of Aldoxorubicin for the Treatment of Relapsed/Refractory Small Cell Lung Cancer 5:00 a.m. Sept. 30, 2014 - PR Newswire - PRF
CytRx Receives Multiple FDA Orphan Drug Designations for Aldoxorubicin for the Treatment of Glioblastoma, Small Cell Lung Cancer and Ovarian Cancer 5:00 a.m. Sept. 29, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼